Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study. Clinics, [S. l.], v. 72, n. 6, p. 378–385, 2017. DOI: 10.6061/clinics/2017(06)08. Disponível em: https://journals.usp.br/clinics/article/view/134124.. Acesso em: 16 jun. 2024.